UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062408
Receipt number R000071420
Scientific Title Factors Associated with Maternal-Infant Bonding in Pregnant and Postpartum Women Receiving Psychiatric Care and the Effects of Newborn Behavioral Observations (NBO) Intervention
Date of disclosure of the study information 2026/07/30
Last modified on 2026/07/30 14:49:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Factors Associated with Maternal-Infant Bonding in Pregnant and Postpartum Women Receiving Psychiatric Care and the Effects of Newborn Behavioral Observations (NBO) Intervention

Acronym

Mother-Infant Bonding and the Effects of the NBO Intervention in Pregnant and Postpartum Women Receiving Psychiatric Care

Scientific Title

Factors Associated with Maternal-Infant Bonding in Pregnant and Postpartum Women Receiving Psychiatric Care and the Effects of Newborn Behavioral Observations (NBO) Intervention

Scientific Title:Acronym

Mother-Infant Bonding and the Effects of the NBO Intervention in Pregnant and Postpartum Women Receiving Psychiatric Care

Region

Japan


Condition

Condition

Psychiatric disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate factors associated with impaired maternal-infant bonding, including childhood trauma, social cognitive functioning, autism spectrum disorder (ASD) traits, lifestyle factors such as screen time, partner-related factors, and ASD traits in the infant. To evaluate the effects of the Newborn Behavioral Observations (NBO) intervention on maternal-infant bonding and infant social development.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mother-to-Infant Bonding Scale (MIBS-J): Third trimester of pregnancy, 1 month postpartum, 4 months postpartum, and 16 months postpartum.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Participants receive the Newborn Behavioral Observations (NBO) intervention in addition to usual psychiatric care.

Interventions/Control_2

Participants receive usual psychiatric care without the NBO intervention.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pregnant women aged 18 years or older who received psychiatric care at our hospital during the study period, their spouses or partners, and their infants.

Key exclusion criteria

Patients who did not provide informed consent, those deemed unsuitable for participation by the attending physician, and mothers younger than 18 years of age and their spouses or partners.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Ayumi
Middle name
Last name Kuramitsu

Organization

Ehime University Hospital

Division name

Department of Neuropsychiatry

Zip code

7910295

Address

454 Shitsukawa, Toon, Ehime

TEL

0899605315

Email

kuramitsu.ayumi.np@ehime-u.ac.jp


Public contact

Name of contact person

1st name Ayumi
Middle name
Last name Kuramitsu

Organization

Ehime University Hospital

Division name

Department of Neuropsychiatry

Zip code

7910295

Address

454 Shitsukawa, Toon, Ehime

TEL

0899605315

Homepage URL


Email

kuramitsu.ayumi.np@ehime-u.ac.jp


Sponsor or person

Institute

Ehime University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science (JSPS)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Ehime University Hospital

Address

454 Shitsukawa, Toon, Ehime

Tel

0899605172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 27 Day

Date of IRB

2026 Year 07 Month 27 Day

Anticipated trial start date

2026 Year 07 Month 31 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 30 Day

Last modified on

2026 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071420